{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T14:02:40Z","timestamp":1790431360740,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100007052","name":"University of Verona","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004710","name":"Fondazione Umberto Veronesi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.bbagen.2018.09.018","type":"journal-article","created":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T21:35:01Z","timestamp":1537997701000},"page":"61-72","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"title":["Pancreatic cancer stem cell proliferation is strongly inhibited by diethyldithiocarbamate-copper complex loaded into hyaluronic acid decorated liposomes"],"prefix":"10.1016","volume":"1863","author":[{"given":"Alessandro","family":"Marengo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Forciniti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Dando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Dalla Pozza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Stella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Tsapis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najet","family":"Yagoubi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppina","family":"Fanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Fattal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Heeschen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Palmieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Arpicco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbagen.2018.09.018_bb0005","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21332","article-title":"Cancer statistics, 2016","volume":"66","author":"Siegel","year":"2016","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bbagen.2018.09.018_bb0010","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1067\/j.cpsurg.2016.01.001","article-title":"Pancreatic adenocarcinoma","volume":"53","author":"Eskander","year":"2016","journal-title":"Curr. Probl. Surg."},{"key":"10.1016\/j.bbagen.2018.09.018_bb0015","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1158\/0008-5472.CAN-06-2030","article-title":"Identification of pancreatic cancer stem cells","volume":"67","author":"Li","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbagen.2018.09.018_bb0020","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.stem.2007.06.002","article-title":"Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer","volume":"1","author":"Hermann","year":"2007","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.bbagen.2018.09.018_bb0025","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1093\/jnci\/djp535","article-title":"Prognostic significance of tumorigenic cells with mesenchymal features in pancreatic adenocarcinoma","volume":"102","author":"Rasheed","year":"2010","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.bbagen.2018.09.018_bb0030","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.stem.2012.05.007","article-title":"Cancer stem cells: current status and evolving complexities","volume":"10","author":"Visvader","year":"2012","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.bbagen.2018.09.018_bb0035","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.stem.2011.10.001","article-title":"Nodal\/Activin signaling drives self-renewal and tumorigenicity of pancreatic cancer stem cells and provides a target for combined drug therapy","volume":"9","author":"Lonardo","year":"2011","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.bbagen.2018.09.018_bb0040","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.3892\/ijo.2014.2796","article-title":"Pancreatic ductal adenocarcinoma cell lines display a plastic ability to bidirectionally convert into cancer stem cells","volume":"46","author":"Dalla Pozza","year":"2015","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbagen.2018.09.018_bb0045","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1158\/1535-7163.MCT-08-0924","article-title":"A direct pancreatic cancer xenograft model as a platform for cancer stem cell therapeutic development","volume":"8","author":"Jimeno","year":"2009","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bbagen.2018.09.018_bb0050","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.biomaterials.2015.08.048","article-title":"Hyaluronic acid-decorated dual responsive nanoparticles of Pluronic F127, PLGA, and chitosan for targeted co-delivery of doxorubicin and irinotecan to eliminate cancer stem-like cells","volume":"72","author":"Wang","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.bbagen.2018.09.018_bb0055","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.colsurfb.2016.03.075","article-title":"CD44 targeted chemotherapy for co-eradication of breast cancer stem cells and cancer cells using polymeric nanoparticles of salinomycin and paclitaxel","volume":"143","author":"Muntimadugu","year":"2016","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.bbagen.2018.09.018_bb0060","first-page":"197","article-title":"Disulfiram induces apoptosis in human melanoma cells: a redox-related process","volume":"1","author":"Cen","year":"2002","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bbagen.2018.09.018_bb0065","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/ijc.21534","article-title":"Inhibition of proteasome activity, nuclear factor-KappaB translocation and cell survival by the antialcoholism drug disulfiram","volume":"118","author":"Lovborg","year":"2006","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbagen.2018.09.018_bb0070","first-page":"1069","article-title":"Disulfiram suppresses invasive ability of osteosarcoma cells via the inhibition of MMP-2 and MMP-9 expression","volume":"40","author":"Cho","year":"2007","journal-title":"J. Biochem. Mol. Biol."},{"key":"10.1016\/j.bbagen.2018.09.018_bb0075","doi-asserted-by":"crossref","first-page":"10425","DOI":"10.1158\/0008-5472.CAN-06-2126","article-title":"Disulfiram, a clinically used anti-alcoholism drug and copper-binding agent, induces apoptotic cell death in breast cancer cultures and xenografts via inhibition of the proteasome activity","volume":"66","author":"Chen","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbagen.2018.09.018_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0093711","article-title":"Disulfiram suppresses growth of the malignant pleural mesothelioma cells in part by inducing apoptosis","volume":"9","author":"Cheriyan","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bbagen.2018.09.018_bb0085","doi-asserted-by":"crossref","first-page":"6070","DOI":"10.1158\/1078-0432.CCR-09-1035","article-title":"High-throughput cell-based screening of 4910 known drugs and drug-like small molecules identifies disulfiram as an inhibitor of prostate cancer cell growth","volume":"15","author":"Iljin","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbagen.2018.09.018_bb0090","doi-asserted-by":"crossref","first-page":"3860","DOI":"10.1158\/1078-0432.CCR-15-1798","article-title":"Disulfiram when combined with copper enhances the therapeutic effects of temozolomide for the treatment of glioblastoma","volume":"22","author":"Lun","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbagen.2018.09.018_bb0095","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.canlet.2009.09.002","article-title":"Disulfiram\/copper complex inhibiting NFkappaB activity and potentiating cytotoxic effect of gemcitabine on colon and breast cancer cell lines","volume":"290","author":"Guo","year":"2010","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbagen.2018.09.018_bb0100","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1158\/1535-7163.1049.3.9","article-title":"Disulfiram inhibits activating transcription factor\/cyclic AMP-responsive element binding protein and human melanoma growth in a metal-dependent manner in vitro, in mice and in a patient with metastatic disease","volume":"3","author":"Brar","year":"2004","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bbagen.2018.09.018_bb0105","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.freeradbiomed.2011.01.001","article-title":"Gemcitabine response in pancreatic adenocarcinoma cells is synergistically enhanced by dithiocarbamate derivatives","volume":"50","author":"Dalla Pozza","year":"2011","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbagen.2018.09.018_bb0110","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.canlet.2016.05.026","article-title":"Disulfiram targets cancer stem-like properties and the HER2\/Akt signaling pathway in HER2-positive breast cancer","volume":"379","author":"Kim","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbagen.2018.09.018_bb0115","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1038\/bjc.2012.442","article-title":"Cytotoxic effect of disulfiram\/copper on human glioblastoma cell lines and ALDH-positive cancer-stem-like cells","volume":"107","author":"Liu","year":"2012","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbagen.2018.09.018_bb0120","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.taap.2013.09.009","article-title":"A binuclear complex constituted by diethyldithiocarbamate and copper(I) functions as a proteasome activity inhibitor in pancreatic cancer cultures and xenografts","volume":"273","author":"Han","year":"2013","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.bbagen.2018.09.018_bb0125","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1093\/carcin\/bgt366","article-title":"Disulfiram is a direct and potent inhibitor of human O6-methylguanine-DNA methyltransferase (MGMT) in brain tumor cells and mouse brain and markedly increases the alkylating DNA damage","volume":"35","author":"Paranjpe","year":"2014","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bbagen.2018.09.018_bb0130","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1021\/mp049917l","article-title":"Disulfiram metabolites permanently inactivate the human multidrug resistance P-glycoprotein","volume":"1","author":"Loo","year":"2004","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.bbagen.2018.09.018_bb0135","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.molonc.2015.02.007","article-title":"Disulfiram (DSF) acts as a copper ionophore to induce copper-dependent oxidative stress and mediate anti-tumor efficacy in inflammatory breast cancer","volume":"9","author":"Allensworth","year":"2015","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.bbagen.2018.09.018_bb0140","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1021\/acsbiomaterials.7b00569","article-title":"Overcoming multidrug resistance through the synergistic effects of hierarchical pH-sensitive, ROS-generating nanoreactors","volume":"3","author":"Kankala","year":"2017","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.bbagen.2018.09.018_bb0145","doi-asserted-by":"crossref","first-page":"86072","DOI":"10.1039\/C5RA16023E","article-title":"Killing cancer cells by delivering a nanoreactor for inhibition of catalase and catalytically enhancing intracellular levels of ROS","volume":"5","author":"Kankala","year":"2015","journal-title":"RSC Adv."},{"key":"10.1016\/j.bbagen.2018.09.018_bb0150","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1039\/C6TB03146C","article-title":"Overcoming multidrug resistance through co-delivery of ROS-generating nano-machinery in cancer therapeutics","volume":"5","author":"Kankala","year":"2017","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.bbagen.2018.09.018_bb0155","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1600-0447.1992.tb03310.x","article-title":"A review of the pharmacokinetics and pharmacodynamics of disulfiram and its metabolites","volume":"369","author":"Johansson","year":"1992","journal-title":"Acta Psychiatr. Scand. Suppl."},{"key":"10.1016\/j.bbagen.2018.09.018_bb0160","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nnano.2007.387","article-title":"Nanocarriers as an emerging platform for cancer therapy","volume":"2","author":"Peer","year":"2007","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.bbagen.2018.09.018_bb0165","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1556-276X-8-102","article-title":"Liposome: classification, preparation, and applications","volume":"8","author":"Akbarzadeh","year":"2013","journal-title":"Nanoscale Res. Lett."},{"key":"10.1016\/j.bbagen.2018.09.018_bb0170","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.2217\/nnm.13.118","article-title":"Current trends in the use of liposomes for tumor targeting","volume":"8","author":"Deshpande","year":"2013","journal-title":"Nanomed. (Lond., Engl.)"},{"key":"10.1016\/j.bbagen.2018.09.018_bb0175","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1517\/17425247.5.9.1003","article-title":"Antibody-modified liposomes for cancer chemotherapy","volume":"5","author":"Torchilin","year":"2008","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.bbagen.2018.09.018_bb0180","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/bip.22678","article-title":"Review peptide-targeted liposomes for selective drug delivery: Advantages and problematic issues","volume":"104","author":"Accardo","year":"2015","journal-title":"Biopolymers"},{"key":"10.1016\/j.bbagen.2018.09.018_bb0185","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00280-009-1132-4","article-title":"Improved therapeutic activity of folate-targeted liposomal doxorubicin in folate receptor-expressing tumor models","volume":"66","author":"Gabizon","year":"2010","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.bbagen.2018.09.018_bb0190","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1021\/bc5004313","article-title":"Functionalizing liposomes with anti-CD44 aptamer for selective targeting of cancer cells","volume":"26","author":"Alshaer","year":"2015","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.bbagen.2018.09.018_bb0195","first-page":"6724","article-title":"Expression of CD44 in pancreatic cancer and its significance","volume":"8","author":"Li","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.bbagen.2018.09.018_bb0200","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3109\/1061186X.2015.1052072","article-title":"Hyaluronic acid targeting of CD44 for cancer therapy: from receptor biology to nanomedicine","volume":"23","author":"Mattheolabakis","year":"2015","journal-title":"J. Drug Target."},{"key":"10.1016\/j.bbagen.2018.09.018_bb0205","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1111\/j.1742-4658.2011.08071.x","article-title":"Hyaluronan-CD44 interactions as potential targets for cancer therapy","volume":"278","author":"Misra","year":"2011","journal-title":"FEBS J."},{"key":"10.1016\/j.bbagen.2018.09.018_bb0210","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ejpb.2013.06.003","article-title":"Hyaluronic acid-coated liposomes for active targeting of gemcitabine","volume":"85","author":"Arpicco","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.bbagen.2018.09.018_bb0215","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/j.bbamem.2013.01.020","article-title":"Targeting gemcitabine containing liposomes to CD44 expressing pancreatic adenocarcinoma cells causes an increase in the antitumoral activity","volume":"1828","author":"Dalla Pozza","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbagen.2018.09.018_bb0220","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/ejlt.201400278","article-title":"Formulation and preparation of a stable intravenous disulfiram-loaded lipid emulsion","volume":"117","author":"Chen","year":"2015","journal-title":"Eur. J. Lipid Sci. Technol."},{"key":"10.1016\/j.bbagen.2018.09.018_bb0225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0153416","article-title":"Nanoscale reaction vessels designed for synthesis of copper-drug complexes suitable for preclinical development","volume":"11","author":"Wehbe","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.bbagen.2018.09.018_bb0230","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S0021-9258(18)70226-3","article-title":"Phosphorus assay in column chromatography","volume":"234","author":"Bartlett","year":"1959","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2018.09.018_bb0235","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.jprot.2016.10.002","article-title":"Proteomic analysis of pancreatic cancer stem cells: Functional role of fatty acid synthesis and mevalonate pathways","volume":"150","author":"Brandi","year":"2017","journal-title":"J. Proteome"},{"key":"10.1016\/j.bbagen.2018.09.018_bb0240","first-page":"e52801","article-title":"Studying pancreatic cancer stem cell characteristics for developing new treatment strategies","author":"Lonardo","year":"2015","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.bbagen.2018.09.018_bb0245","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.2174\/138955712802762040","article-title":"Dithiocarbamate-based coordination compounds as potent proteasome inhibitors in human cancer cells","volume":"12","author":"Buac","year":"2012","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.bbagen.2018.09.018_bb0250","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1124\/mol.64.5.1076","article-title":"Inhibition of invasion and angiogenesis by zinc-chelating agent disulfiram","volume":"64","author":"Shian","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bbagen.2018.09.018_bb0255","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.2147\/IJN.S137347","article-title":"Development and optimization of an injectable formulation of copper diethyldithiocarbamate, an active anticancer agent","volume":"12","author":"Wehbe","year":"2017","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.bbagen.2018.09.018_bb0260","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nrc3803","article-title":"Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles' heel?","volume":"14","author":"Sabharwal","year":"2014","journal-title":"Nat. Rev. Cancer"}],"container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304416518303064?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304416518303064?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T16:38:45Z","timestamp":1662136725000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304416518303064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S0304416518303064"],"URL":"https:\/\/doi.org\/10.1016\/j.bbagen.2018.09.018","relation":{},"ISSN":["0304-4165"],"issn-type":[{"value":"0304-4165","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pancreatic cancer stem cell proliferation is strongly inhibited by diethyldithiocarbamate-copper complex loaded into hyaluronic acid decorated liposomes","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - General Subjects","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbagen.2018.09.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}